0001127602-24-009540.txt : 20240311 0001127602-24-009540.hdr.sgml : 20240311 20240311205954 ACCESSION NUMBER: 0001127602-24-009540 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240310 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dickinson Andrew D CENTRAL INDEX KEY: 0001310204 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 24739995 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES, INC. CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: GILEAD SCIENCES INC DATE OF NAME CHANGE: 19930328 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-03-10 0000882095 GILEAD SCIENCES, INC. GILD 0001310204 Dickinson Andrew D GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 Chief Financial Officer 0 Common Stock 2024-03-10 4 M 0 3025 A 132781 D Common Stock 2024-03-10 4 M 0 6707 A 139488 D Common Stock 2024-03-10 4 F 0 4505 75.12 D 134983 D Restricted Stock Unit 2024-03-10 4 M 0 3025 D Common Stock 3025 35040 D Restricted Stock Unit 2024-03-10 4 M 0 6707 D Common Stock 6707 28333 D Non-qualified Stock Option (Right to Buy) 75.12 2024-03-10 4 A 0 87970 0 A 2034-03-10 Common Stock 87970 87970 D Restricted Stock Unit 2024-03-10 4 A 0 17305 A Common Stock 17305 46407 D Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan. The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested. The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. The options have a four year vesting schedule. 25% vest on the first anniversary date of the date grant. The balance will vest 6.25% quarterly thereafter until fully vested. /s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson 2024-03-11